KAGIYAMA S, FUKUHARA M, MATSUMURA K, et al. Central and peripheral cardiovascular actions of apelin in conscious rats[J]. Regul Pept, 2005, 125(1-3):55-59.
[2]
LEE DK, CHENG R, NGUYEN T, et al. Characterization of Apelin, the ligand for the APJ receptor[J]. J Neurochem, 2000, 74(1):34-41.
[3]
SHANASUZZAMAN AS, GERSH BJ, SOMERS VK. Obstructive sleep apnea: implications for cardiac and vascular disease[J]. JAMA, 2003, 290:1906-1914.
[4]
FLEETHAM JA. Is chronic obstructive pulmonary disease related to sleep apnea hypopnea syndrome[J]. Am J Respir Crit Care Med, 2003, 167:3-4.
[5]
JELIC S, PADELETTI M, KAWUT SM, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea[J]. Circulation, 2008, 117(17):2270-2278.
[6]
IMAI Y, KUBA K, RAO S, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure[J]. Nature, 2005, 436:112-116.
IWAI M, HORIUCHI M. Devil and angel in the renin-angiotensin system: ACE-angiotensin Ⅱ-AT1 receptor axis vs ACE2-angiotensin-(1-7) -Mas receptor axis[J]. Hypertens Res, 2009, 32:533-536.
[9]
HOSOYA M, KAWAMATA Y, FUKUSUMI S, et al. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand Apelin[J]. J Biol Chem, 2000, 275(28):21061-21067.
JIA YX, PAN CS, ZHANG J, et al. Apelin protects myocardial in jury induced by isoproterenol in rats[J]. Regul Pept, 2006, 133(1-3):147-154.
[12]
COOK DR, GLEICHMAN AJ, CROSS SA, et al. NMDA receptor modulation by the neuropetide apelin: implication for excitotoxic injury[J]. J Neurochem, 2011, 118:1113-1123.
CHEN LN, YANG XH, NISSEN DH, et al. Dysregulated renin-angiotensin system contributes to acute lung injury caused by hind-limb ischemia-reperfusion in mice[J]. Shock, 2013, 40:420-429.
[15]
GOETZE JP, REHFELD JF, CARLSEN J, et al. Apelin:a new plasma marker of cardiopulmonary disease[J]. Regul Pept, 2006, 133(1-3):134-138.